13:09 EST 14th December 2018 | BioPortfolio

A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with inventors and institutions. Drug Royalty has completed more than 20 transactions and invested in excess of $100 million since its inception


M5J 2J3


Phone: 416-863-1865
Fax: 416-863-5161

News Articles [744 Associated News Articles listed on BioPortfolio]

Clarus provides Galera with $80mm through royalty financing tied to musositis drug sales

Cancer drug developer Galera Therapeutics Inc. entered an $80mm royalty financing agreement with Clarus (which also participated in Galera's concurrent $70mm Series C round). Under the royalty financi...

#Cannabisstocks: Tidal Royalty (CSE: RLTY.U) (OTC: TDRYF) and CannaRoyalty (CSE: CRZ) (OTC: CNNRF) Agree to Terms On Purchase of AltMed Royalty and Equity

Toronto, Ontario - August 27, 2018 (Newsfile Corp.) ( Newswire) Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) ("Tidal Royalty"), a leading provider of royalty financing to licensed U...

Zealand Abandons Sanofi Diabetes Drug in $205 Million Deal with Royalty Pharma

Copenhagen-based Zealand Pharma is selling future royalty streams and $85 million in potential commercial milestones for two diabetes drugs, Soliqua/Suliqua and Lyxumia/Adlyxin, to New York-based Roya...

Royalty, Zealand to enter deal on diabetes drugs

Royalty Pharma will acquire Zealand Pharma's royalty rights and potential commercial milestones worth $85 million tied to Lyx -More- 

#Cannabisstocks: Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) Announces Listing on United States OTC Market

Toronto, Ontario - July 16, 2018 (Newsfile Corp.) ( Newswire) Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) ("Tidal Royalty" or the "Company"), a leading provider of royalty financin...

Zealand Pharma sells Soliqua and Lyxumia royalty interests to Royalty Pharma for $205mm

Zealand Pharma AS agreed to sell future royalty streams and $85mm in potential milestone payments related to its diabetes drugs Soliqua 100/33/ Suliqua (insulin glargine/lixisenatide) and Lyxumia/Adly...

#Cannabisstocks; Tidal Royalty Corp. (CSE: RLTY) Commences Trading on Canadian Securities Exchange & Adds Industry Leaders to its Advisory Board

Toronto, Ontario - June 25, 2018 (Newsfile Corp.) ( Newswire) Tidal Royalty Corporation (CSE: RLTY) ("Tidal Royalty" or "the Company"), a leading provider of royalty financing to the ...

#Cannabisstocks: Tidal Royalty Corp. (CSE: RLTY.U) Announces Letter of Intent to Finance Massachusetts Expansion

Toronto, Ontario - July 3, 2018 (Newsfile Corp.) ( Newswire) Tidal Royalty Corp. (CSE: RLTY.U) ("Tidal Royalty"), a leading provider of royalty financing to licensed US cannabis opera...

PubMed Articles [2346 Associated PubMed Articles listed on BioPortfolio]

Defining Treatment Effects: A Primer for Non-Statisticians.

It would often be of interest to know the effect of a drug, compared to control, in people who take the drug. However, different people will likely take drug and control. Then comparing takers of drug...

Progress in Research Drug Eluting Stents Drug-looding and Drug Release Kinetics.

Drug eluting stents are one of the main devices of coronary intervention, which play a therapeutic role through the combination of medical devices. Drug is an important part of the drug eluting stents...

Synthetic drug use and HIV infection among men who have sex with men in China: A sixteen-city, cross-sectional survey.

Increasing evidence suggests an association between synthetic drug use and HIV infection among men who have sex with men (MSM). The aim of this study was to evaluate synthetic drug use prevalence, des...

TAIJI: Approaching Experimental Replicates-Level Accuracy for Drug Synergy Prediction.

Combination therapy is widely used in cancer treatment to overcome drug resistance. High-throughput drug screening is the standard approach to study the drug combination effects, yet it becomes imprac...

The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.

As the name suggests, drug repurposing is a strategy to identify new therapeutic uses for marketed drugs, discontinued and/or shelved drugs, and drug candidates currently in clinical development. Alth...

Clinical Trials [2317 Associated Clinical Trials listed on BioPortfolio]

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent

DDI Effectiveness and Clinical Awareness

The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and...

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

The investigators hypothesize that in a real-world population undergoing percutaneous coronary intervention (PCI) for de-novo stenoses in small native vessels with a diameter

Companies [1471 Associated Companies listed on BioPortfolio]


A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

Drug Royalty

Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...

DRI Capital Inc.

DRI is a pioneer and global leader in healthcare royalty investing and has completed transactions with large global pharmaceutical companies, biotechnology companies, universities...

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...

More Information about "DRUG ROYALTY CORPORATION INC" on BioPortfolio

We have published hundreds of DRUG ROYALTY CORPORATION INC news stories on BioPortfolio along with dozens of DRUG ROYALTY CORPORATION INC Clinical Trials and PubMed Articles about DRUG ROYALTY CORPORATION INC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DRUG ROYALTY CORPORATION INC Companies in our database. You can also find out about relevant DRUG ROYALTY CORPORATION INC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record